Overview
In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).
Eligibility
Inclusion Criteria:
- Patients with biopsy-proven endometrial cancer;
- Women aged > 18 years old;
- Signed Informed consent.
Exclusion Criteria:
- Previous history of neoplasm;
- Concurrent malignancies at other sites.